Report : A-Z NHS England items in Formulary 05/03/2021 23:22:11

[Back]

Section Status NHS England Name 08.01.05 Formulary Abemaciclib Verzenios® 08.01.05 Formulary Abemaciclib Verzenios® 11.04.02 Formulary Adalimumab injection Imraldi ® Amgevita ® Humira® 08.01.05 Formulary Alectinib Alecensa® 03.04.02 Formulary Benralizumab Fasenra® 08.01.05 Formulary Bevacizumab Avastin® 05.03.01 Formulary Bictegravir 50mg emtricitabine 200mg tenofovir alafenamide 25mg Biktarvy 08.01.05 Formulary Binimetinib Mektovi ® 08.01.05 Formulary Brigatinib Alunbrig® 04.08.01 Formulary Cannabidiol Epidyolex 09.01 Formulary Caplacizumab Cablivi® 09.05.01.02 Formulary Cinacalcet Mimpara® 08.01.05 Formulary Dacomitinib monohydrate Vizimpro® 08.03.04.02 Formulary Darolutamide Nubeqa® 08.01.05 Formulary Dinutuximab beta Qarziba® 05.03.01 Formulary Dolutegravir/lamivudine Dovato® 05.03.01 Formulary Dolutegravir/rilpivine Juluca® 08.01.05 Formulary Encorafenib Braftovi® 08.01.05 Formulary Gemtuzumab ozogamicin Mylotarg® 08.02.04 Formulary Glatiramer Acetate Copaxone® 10.02 Formulary Interferon beta-1a Avonex®, Rebif® 10.02.01 Formulary Interferon beta-1b Extavia® 03.07 Formulary Ivacaftor  03.04.03 Formulary Lanadelumab Takhzyro® 05.03.02.02 Formulary Letermovir Prevymis® 08.01.05 Formulary Liposomal cytarabine-daunorubicin Vyxeos® 08.01.05 Formulary Lorlatinib Lorviqua® 03.07 Formulary Lumacaftor/Ivacaftor Orkambi® 08.01.05 Formulary Lutetium (177Lu) oxodotretide Lutathera® 08.01.05 Formulary Midostaurin Rydapt® 08.01.05 Formulary Neratinib  Nerlynx ® 10.02 Formulary Nusinersen Spinraza® 08.02.04 Formulary Ocrelizumab Ocrevus® 10.02.01 Formulary Peginterferon beta 1a Plegridy® 05.03 Restricted Use Remdesivir  08.02.04 Formulary Siponimod Mayzent 03.07 Formulary Tezacaftor/Ivacaftor Symkevi®

Portsmouth and South East Hampshire